Saumil Gandhi MD PhD
Assistant Professor, University of Texas MD Anderson Cancer Center
Join to view full profile
1515 Holcombe BlvdUnit 97Houston, TX 77030
Phone+1 713-563-7775
Dr. Gandhi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemResidency, Radiation Oncology, 2012 - 2016- University of Pennsylvania Health SystemResidency, Internal Medicine, 2011 - 2012
Albert Einstein College of MedicineClass of 2011
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2016 - 2026
OK State Medical License 2020 - 2021
PA State Medical License 2011 - 2016
American Board of Radiology Radiation Oncology
Clinical Trials
- Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies Start of enrollment: 2023 May 08
Roles: Principal Investigator, Contact
- NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer Start of enrollment: 2021 Feb 10
Roles: Principal Investigator, Contact
- Feasibility, Safety, and Efficacy of Stereotactic MRI-Guided Adaptive Radiation Therapy (SMART) for Central Lung Tumors Start of enrollment: 2022 Nov 17
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Long-Term Outcomes After Proton Therapy Versus Intensity Modulated Photon Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cance...Tingshi Su, Ting Xu, Mei Chen, Xinru Chen, Quynh-Nhu Nguyen
International Journal of Radiation Oncology, Biology, Physics. 2026-11-15 - Using Induction Chemoimmunotherapy as a Bridge to Definitive Local Therapy for Non-Metastatic NSCLC: Real-World Outcomes From a Comprehensive Cancer Center.Troy J Kleber, Sage A Copling, Andrew D Kim, César P Márquez, Wenli Dong
Clinical Lung Cancer. 2026-10-01 - 1 citationsSARS-CoV-2 mRNA Vaccination Improved Survival in NSCLC Treated With Radiotherapy.Xinyan Xu, Maliazurina B Saad, Adam Grippin, Hui Xu, Amgad Muneer
Journal of Thoracic Oncology. 2026-10-01
Journal Articles
- Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?☆Zhongxing Liao, Saumil J Gandhi, Steven H Lin, ScienceDirect
Press Mentions
Updates in EGFR-Mutated Oligometastatic NSCLCJune 14th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: